Cerave Developed With Dermatologists Bha Exfoliating Toner Acne Treatment Liquid
Product Images NDC 82046-291

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cerave Developed With Dermatologists Bha Exfoliating Toner Acne Treatment (NDC 82046-291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by L'oreal Usa Products Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Back 237 (237 Back)

This text provides information about an acne treatment product containing 2% salicylic acid. It is designed to treat acne blemishes and blackheads, promote skin healing, and prevent new blemishes. The directions recommend applying a thin layer to the affected area one to three times daily after cleaning the skin. It also advises starting with one application daily to prevent excessive dryness and irritation. The product's inactive ingredients include various substances like water, glycerin, and niacinamide. Additionally, the text includes warnings about possible skin irritation and dryness, as well as advice on not using multiple topical acne medications simultaneously.*

FDA Label Image

Front 237 (237)

This is a BHA exfoliating toner developed with dermatologists. It contains 2% salicylic acid for acne treatment. The toner helps unclog and minimize the appearance of pores, smooth skin's texture, and leave skin refreshed. Additionally, it maintains the protective skin barrier. The product comes in a 8 fl oz (237 ml) size.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.